Biblio

Digital microfluidic biochips (DMFBs) have become popular in the healthcare industry recently because of its lowcost, high-throughput, and portability. Users can execute the experiments on biochips with high resolution, and the biochips market therefore grows significantly. However, malicious attackers exploit Intellectual Property (IP) piracy and Trojan attacks to gain illegal profits. The conventional approaches present defense mechanisms that target either IP piracy or Trojan attacks. In practical, DMFBs may suffer from the threat of being attacked by these two attacks at the same time. This paper presents a comprehensive security system to protect DMFBs from IP piracy and Trojan attacks. We propose an authentication mechanism to protect IP and detect errors caused by Trojans with CCD cameras. By our security system, we could generate secret keys for authentication and determine whether the bioassay is under the IP piracy and Trojan attacks. Experimental results demonstrate the efficacy of our security system without overhead of the bioassay completion time.

As digital microfluidic biochips (DMFBs) make the transition to the marketplace for commercial exploitation, security and intellectual property (IP) protection are emerging as important design considerations. Recent studies have shown that DMFBs are vulnerable to reverse engineering aimed at stealing biomolecular protocols (IP theft). The IP piracy of proprietary protocols may lead to significant losses for pharmaceutical and biotech companies. The micro-electrode-dot-array (MEDA) is a next-generation DMFB platform that supports real-time sensing of droplets and has the added advantage of important security protections. However, real-time sensing offers opportunities to an attacker to steal the biochemical IP. We show that the daisychaining of microelectrodes and the use of one-time-programmability in MEDA biochips provides effective bitstream scrambling of biochemical protocols. To examine the strength of this solution, we develop a SAT attack that can unscramble the bitstreams through repeated observations of bioassays executed on the MEDA platform. Based on insights gained from the SAT attack, we propose an advanced defense against IP theft. Simulation results using real-life biomolecular protocols confirm that while the SAT attack is effective for simple instances, our advanced defense can thwart it for realistic MEDA biochips and real-life protocols.